BACKGROUND: Histological features and Ki-67 index have known usefulness in predicting prognosis and guiding therapy among patients with metastatic pancreatic neuroendocrine neoplasms. Fine-needle aspiration may offer advantages for Ki-67 assessment because the technique obtains highly cellular, well-preserved specimens with the potential for broader tumor sampling. In the current study, the authors evaluated concordance for grade and differentiation between concurrent core needle biopsy and cytology preparations. Cytological features and grade then were correlated with survival.
INTRODUCTION
Pancreatic neuroendocrine neoplasms are rare, pathologically diverse tumors with varied clinical behavior. The tumor morphology and proliferative rate are key aspects of tumor prognostication and, accordingly, these elements form the basis of the tumor classification system outlined by the World Health Organization (WHO) 2010 classification of digestive system tumors. 1 In this system, well-differentiated (WD) neuroendocrine tumors (NETs) morphologically resemble nonneoplastic islet cells, whereas poorly differentiated (PD) neuroendocrine carcinomas (NECs) are uniformly high grade and exhibit large cell or small cell morphology. The distinction between WD and PD tumors is supported by different underlying genetic alterations and is clinically significant for different behaviors and vastly divergent treatment strategies. [2] [3] [4] The tumors are categorized further into 3 tumor grades distinguished by mitotic rate or Ki-67 proliferation rate: low grade (<3%), intermediate grade (3%-<20%), and high grade (>20%). 1 PD-NEC is uniformly high grade, whereas WD tumors can exhibit a spectrum from low to high grade. 5 Tumor grade based on histological analysis has been demonstrated to stratify patient survival among individuals with primary and metastatic tumors. 6, 7 The liver is a common site for metastasis from pancreatic neuroendocrine neoplasms, which can be present at the time of initial diagnosis or occur during the course of tumor progression. Biopsy of the liver is performed for initial tumor diagnosis, staging, and/or confirmation of metastasis. Of paramount importance, tumor differentiation must be established. The grade of liver metastasis from WD-NETs also is clinically important both for prognostication and evaluation of grade progression because WD-NET can demonstrate transitions from low to intermediate grade and even to high grade. 3 Core needle biopsy grading has been shown to correlate with grading of resected liver metastasis from pancreatic NETs, although underestimation of grade can occur due to tumor heterogeneity. 7 The biopsy modality used to assess liver masses is nonuniform and on occasion cytology may be the only available material with which to assess these necessary diagnostic and prognostic parameters. Fineneedle aspiration (FNA) may offer advantages for assessment of the Ki-67 proliferation index because the technique obtains highly cellular, well-preserved specimens with the potential for broad tumor sampling compared with core needle biopsy. However, the cells are dispersed across the slide in smears and liquid-based preparations and to our knowledge it is not clear how this may affect Ki-67 assessment and tumor grade. Furthermore, tumor preservation may differ in FNA specimens compared with core needle biopsies, which theoretically can affect the observed proliferative rate. To the best of our knowledge, there is limited knowledge regarding the usefulness of the Ki-67 index in this specific context. 8, 9 This study of metastatic pancreatic neuroendocrine neoplasms involving the liver had 2 aims: 1) to compare the assessment of tumor grade and differentiation between concurrent core needle biopsy and among various cytology preparations; and 2) to evaluate the value of cytology grade by the Ki-67 proliferation index in predicting cancerspecific survival.
MATERIALS AND METHODS
The current study was performed retrospectively including cases diagnosed between 2001 and 2013. A total of 44 patients with pancreatic neuroendocrine neoplasms metastatic to the liver and an available cytology specimen were identified from a hospital database. Clinical history and follow-up information were obtained for all patients from the electronic medical record. Survival was calculated for individuals from the date of diagnosis until the date of death or last clinical assessment. For survival analysis, individuals with no date of death were censored at the date of the last clinical appointment. Cause of death was determined from the last clinical assessment. The progressionfree interval was not calculated because the majority of patients presented with stage IV disease.
Pathological Assessment
Cytology material from the 44 patients consisted of 34 FNA specimens alone and 10 touch preparation cytology specimens from a core needle biopsy (with or without needle rinse). This cohort had 19 concurrently obtained core needle biopsies (9 of 34 FNA specimens had a concurrent core needle biopsy) (Fig. 1) . Routine cytological preparations consisted of an average of 5.5 slides (range, 1-12 slides) per patient comprising a combination of airdried smears stained with Diff-Quik, alcohol-fixed smears (stained using the hematoxylin and eosin and Papanicolaou methods), ThinPrep (Hologic Inc, Marlborough, Mass), and hematoxylin and eosin-stained cell blocks. The aspiration needle was rinsed in CytoLyt solution (Cytyc Corporation, Marlborough, Mass), and this material was used to prepare a ThinPrep slide and cell block. Core needle biopsy preparations (typically using an 18-gauge needle) consisted of 1 hematoxylin and eosin-stained section per case. The following parameters were assessed: differentiation, nuclear size, oncocytic cytoplasm, necrosis, conspicuous mitotic activity (defined as > 3 mitotic figures), and frequent apoptotic bodies. WD was defined as small-sized to intermediatesized plasmacytoid cells with round to ovoid nuclei, with smooth nuclear membranes and finely granular chromatin as commonly described for islet cell tumors 10 and PD was defined as meeting conventional morphological criteria for small cell carcinoma (nuclear molding, hyperchromatic coarse chromatin, and minimal cytoplasm) or features of large cell NEC (large nuclei, abundant cytoplasm, large vesicular nuclei, prominent nucleoli, and necrosis). Nuclear size was categorized as large if greater than twice the size of a resting hepatocyte nucleus.
Immunohistochemistry
Ki-67 proliferation rate by immunohistochemistry was assessed for all cases using a combination of various preparations (core needle biopsy, cell block, alcohol-fixed cytology smear, or ThinPrep) depending on the availability of materials as outlined in Figure 1 . Paraffin-embedded cell block and core needle biopsies were stained with Ki-67 monoclonal antibody (clone30-9 [no dilution]; Ventana Medical Systems, Tucson, Ariz) using the standard automated immunohistochemistry on a BenchMark XT automated system (Ventana Medical Systems). Alcohol-fixed slides were destained and restained with monoclonal Ki-67 antibody (clone MIB-1 [1:100 dilution]; Dako, Carpinteria, Calif) using the avidin-biotin-peroxidase detection system (Ventana Medical Systems). For all preparation types, Ki-67 proliferation rate assessment was performed manually via 2 to 4 digital images obtained at 320 magnification (Olympus DP21 microscope camera; Olympus Corporation of the Americas, Center Valley, Pa) in cellular areas with an increased concentration of labeled cells and a monolayer distribution of cells (on cytology smears). All positively and negatively stained tumor nuclei in each digital image were counted. Ki-67 immunoreactivity was expressed as the percentage of tumor cells with positive nuclear staining. Based on the Ki-67 proliferation rate, the multiple preparations per case were each assigned a grade from 1 to 3 (grade 1: < 3%; grade 2: 3%-20%; and grade 3: >20%) and designated as "smear grade," "cell block grade," or "core grade" for each case.
Statistical Analysis
The predictive values of smear grade, cell block grade, and core needle biopsy grade were evaluated separately for the correlation with survival using Cox regression adjusting for tumor stage. Three cases did not have a smear/ThinPrep slides available, and therefore analysis also was performed using the smear grade including cell block grade and this was designated the "aggregate cytology grade." Second, we evaluated the association between cytomorphologic features (differentiation assessed on cytology smear, nuclear size, oncocytic cytoplasm, necrosis, conspicuous mitotic activity, and frequent apoptotic bodies) using unadjusted Cox regression. Differentiation based on assessment of the smear was used for survival analysis because the smear was the only preparation available for all cases. All analyses were conducted using STATA statistical software (version 13; StataCorp LP, College Station, Tex). The threshold for significance was set at P 5 .05.
RESULTS
The 44 patients consisted of 29 men and 15 women. For the entire cohort, the median age at the time of diagnosis was 61 years (range, 36-82 years). Approximately 84% of the patients (37 patients) had stage IV disease at the time of presentation. Hepatic metastases developed during the course of follow-up in 7 patients and the liver biopsy included in the study was performed to confirm progression of disease. At the time of detection of liver metastasis, 68% of patients (30 patients) had multiple foci of hepatic disease. Clinical characteristics including therapy are summarized in Table 1 . To the best of our knowledge, there is no standardized effective therapy for pancreatic NET. Therapy included the following agents in variable combinations and sequences: etoposide, cisplatin, dacarbazine, capecitabine, temozolomide, bevacizumab, everolimus, sunitinib, and/or temsirolimus. The distribution of tumor grade and differentiation as assessed using each type of biopsy or cytology preparation is shown in Table 2 . The mean Ki-67 index (using smear) for WD was 13% (range, 0%-42%) and that for PD was 47% (range, 30%-60%). During the follow-up period, 31 patients died (71%), 97% due to neuroendocrine malignancy. All patients who were alive at the end of follow-up were found to have persistent disease. The length of follow-up for the surviving patients ranged from 35 to 86 months, with a median of 73 months.
Tumor Differentiation: Assessment and Predictive Value
Agreement for morphologic differentiation between smear and cell block, smear and core needle biopsy, and cell block and core needle biopsy was 30 of 34 cases (88%), 18 of 19 cases (95%), and 10 of 12 cases (83%), respectively, as detailed in Table 3 . Some tumors demonstrated a disagreement with regard to the interpretation of differentiation as WD versus PD across the various preparations. Differentiation disagreements occurred in 4 tumors, with the Ki-67 index ranging from 14% to 45% ( Fig. 2A  and 2B ). Two of the tumors with differentiation disagreements were grade 3 by the Ki-67 index on all preparations and the other 2 tumors had a grade 3 core needle biopsy and grade 2 cytology (smear and/or cell block) result. Tumor differentiation using the cytology smear preparations was found to be the strongest predictor of outcome, with a hazard ratio [HR] of 8.3 (95% confidence interval [95% CI], 3.1-22.1; P<.001) and a median survival of 45 months for WD tumors and 3 months for PD tumors (P<.001). A diagnosis of a PD-NEC on cell block also was found to be associated with worse survival (HR, 3.7; 95% CI, 1.2-11.3). Disease-specific survival based on tumor differentiation combined with aggregate cytology grade is shown in Figure 3C .
Tumor Grade: Assessment and Predictive Value
Tumor grade as determined by the Ki-67 index was compared between preparations for each individual case. Agreement for grade between smear and cell block, smear and core needle biopsy, and cell block and core needle biopsy was 19 of 28 cases (68%), 6 of 11 cases (55%), and 2 of 9 cases (22%), respectively. A breakdown of comparisons between preparation and grade is shown in Table 4 . Grade discrepancies between preparations were accounted for by 14 tumors, representatively illustrated in Figures 2C to 2F . The 14 tumors with grade disagreements had a higher core needle biopsy grade compared with cytology (cell block or smear). Cases with a grade disagreement included 11 WD tumors and 3 tumors with differentiation disagreements (but overall favored to be WD after rereview using information from all preparations). The difference in the Ki-67 index between discrepantly graded core needle biopsy/ cytology was substantial for the majority of cases (median, 23%; range, 2%-64%). Analysis of paired smear/cell blocks with grade disagreements did not demonstrate a consistent pattern similar to that noted above; however, all cases with disagreements between cytology grades using various preparations were WD. In summary, all grade disagreements occurred within WD tumors and when the core needle biopsy grade disagreed with the cytology grade, the core needle biopsy grade was higher. Aggregate cytology grade (graded by smear and 3 cell blocks) strongly predicted survival, with an HR of 1.9 (95% CI, 1.2-2.9) for each ascending grade. The median survival projections by aggregate cytology grade were 121 months (95% CI, 57-185 months [estimated]) for grade 1, 45 months (95% CI, 29-87 months) for grade 2, and 19 months (95% CI, 1-44 months) for grade 3. Survival projections for 2-year, 5-year, and median overall survival by preparation type (aggregate cytology grade, cell block, and core needle biopsy) are shown in Table 5 . Overall survival and disease-specific survival were similar because the majority of deaths were due to the neuroendocrine Grading Metastatic Neuroendocrine Neoplasms/Sigel et al
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malignancy. Using unadjusted survival analyses, the aggregate cytology grade was found to be predictive of diseasespecific survival (P 5 .03) (Fig. 3A) . In multivariate survival analyses, the aggregate cytology grade strongly predicted disease-specific survival for each ascending grade, adjusted for tumor stage, with an HR of 4.2 (95% CI, 2.0-9.3; P<.001). Survival analysis was attempted on the limited subset with grade determined by Ki-67 staining on cell block (32 cases) and core needle biopsy (18 cases); both demonstrated inferior performance for predicting survival (P 5 .4 [ Fig. 3B ] and P 5 .2, respectively).
Predictive Value of Selected Cytomorphologic Features
In stage-adjusted analysis, necrosis (P<.001) and conspicuous apoptosis (HR, 3.6; 95% CI, 1.7-7.8 [P 5 .001]) were found to be significantly associated with survival. Conspicuous mitotic activity was associated with worse outcome in an unadjusted analysis (HR, 3.1; 95% CI, 1.3-7.9) but not after adjustment for disease stage. Oncocytic features (P 5 .4) and nuclear size (P 5 .1) were not found to be significantly associated with survival differences.
DISCUSSION
To the best of our knowledge, this is the largest study to date of metastatic pancreatic neuroendocrine neoplasms evaluating the predictive value of grade as determined by the Ki-67 index on cytology specimens using the 2010 WHO grading system. Grading by cytologic Ki-67 index may not exactly correlate with concurrent core needle biopsy, but grade as determined by staining a smear preparation with the Ki-67 antibody is a good predictor of survival based on stage-adjusted analysis. Grading discrepancies between cytology and core needle biopsy were present primarily in WD-NETs, highlighting the heterogeneity of this group of tumors, 7 and in the majority of cases cytology suggested a lower grade compared with core needle biopsy. Grading by cell block did not achieve significance for predicting survival, and a possible limitation of this preparation is low cellularity in cell blocks, which can lead to lower cell counts for determining the Ki-67 index.
There is overlap in the documented range of the Ki-67 index across WD-NET (Ki-67 index of 0%-42%) from PD-NEC (Ki-67 index of 30%-60%) and therefore there is no appropriate Ki-67 "cutoff" with which to separate these 2 biologically distinct entities. 5, 11 Furthermore, WDNETs can demonstrate a wide spectrum of grade heterogeneity, as shown in this cohort and in previous studies. 7, 12 Therefore, the accurate assessment of differentiation is essential but, unlike quantitative Ki-67 assessment, determination of differentiation is subjective and challenges in the histomorphologic assessment of differentiation in these tumors have been described previously. 13 In the current study, morphological distinction between WD and PD neoplasms was found to be highly predictive of survival, thereby supporting the usefulness of cytomorphology, particularly cytology smears, in distinguishing these biologically distinct tumor types (Fig. 3C ). 14 It is interesting to note that in our cohort the PD tumors consisted of 4 of the small cell type and only 1 large cell type. The small number of cases in the PD group highlights the rarity of the entity, which contributes to the general challenge of making the morphologic distinction between PD-NEC of non-small cell subtype and WD-NET with a high (grade 3) grade. 13 Of the 2 subtypes of PD-NEC, the small cell subtype generally has a more distinctive appearance whereas the large cell type may share features of WD tumors, including nuclear enlargement, prominent nucleoli, and oncocytic cytoplasm. We identified a small number of cases in which tumor differentiation was discrepant between cytology and histology when certain preparations were evaluated in isolation, such as smear or cell block. This is not typical of routine practice, in which findings observed across various preparations are used in concert for the overall interpretation. These cases with differentiation disagreements variably exhibited molding, inconspicuous cytoplasm, apoptotic bodies, and mitotic activity on smears. In summary, evaluating for morphologic characteristics to establish differentiation is crucial because the Ki-67 index cannot be used to determine differentiation, and ancillary information supporting tumor biology such as a molecular profile may not always be available or feasible. The biopsy modality (core needle biopsy vs FNA) chosen for the assessment of liver masses is generally nonuniform, which restricted the cohort size of patients who had concurrent FNA and core needle biopsy. Therefore, in addition to direct comparison between cytology and core needle biopsy differentiation and grade, we tested the correlation of cytology grade with survival. Results of the current study indicated a loss of predictive value for cytology grading of WD-NETs when PD-NECs were removed from the analysis. This may reflect a limitation of the cohort, which contained a substantial component of grade 2 tumors and a limited number of WD grade 3 tumors (5 tumors). Therefore, we were unable to establish whether cytology could demonstrate a differential outcome between grade 2 and grade 3 WD-NETs. Histological high-grade WD-NET has been shown to have a differential outcome in a larger cohort. 3 We identified some technical challenges inherent to the methodology of performing immunohistochemistry on destained slides. Slide selection is important because thick smears cannot be counted accurately due to overlapping nuclei; a substantial component with a monolayer is necessary. Other limitations include heavy background staining, which leads to difficulties in establishing a threshold for positive Ki-67 staining. Weak counterstaining also can influence the ability to accurately count negative nonneuroendocrine nuclei. These factors can limit the proliferation index assessment to certain areas of the slides, which may not represent the highest areas of Ki-67 staining. The substantial differences in the Ki-67 index observed on discrepantly graded core needle biopsy specimens versus smears raises the possibility that technical issues impacted grading.
Furthermore, the results of the current study underscore the importance of using a validated immunohistochemistry protocol for Ki-67 proliferation assessment because certain antibodies have reduced staining on cell block preparations with variable exposure to alcohol fixation. 15 Morphologic assessment can accurately assess tumor differentiation in cytology. Grading of WD-NET benefits from immunohistochemical studies for Ki-67. Grading of these tumors using the Ki-67 proliferation index as performed on cytology smear preparations has prognostic and predictive value using the 2010 WHO classification system.
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